Endoscopic Submucosal Dissection vs Local Laparoscopic Surgical Resection (TAMIS/TEO) in Early Rectal Neoplasias
DSETAMIS2018
1 other identifier
interventional
70
1 country
3
Brief Summary
A multicenter non-inferiority randomized clinical trial to compare Endoscopic treatment (ESD) and Minimally Invasive Laparoscopic Local Surgical Treatment (TAMIS or TEO) for early rectal neoplastic lesions (adenoma \& T1CRC) Primary aim: To compare the long-term local recurrence rate (12 months after the procedure) Secondary aims: Compare en-bloq resection rate, R0 resection, time per procedure, short-term recurrence rate, safety (rate of complications), morbidity and cost-effectiveness analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 16, 2019
CompletedFirst Posted
Study publicly available on registry
May 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedJune 3, 2025
May 1, 2025
5.7 years
May 16, 2019
May 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
local recurrence rate
presence of remaining neoplastic tissue in resection site
12 months
Secondary Outcomes (9)
En-bloq resection rate
1 hour
R0 resection rate
1 hour
Time per procedure
1 hour
Length of hospital stay
1 hour
Early complications rate
1 hour
- +4 more secondary outcomes
Study Arms (2)
Endoscopic Treatment
EXPERIMENTALRectal Endoscopic Submucosal Dissection
Minimally Invasive Laparoscopic Local Surgical Treatment
EXPERIMENTALTransanal Minimally Invasive Surgery (TAMIS) or Transanal Endoscopic Operation (TEO)
Interventions
Eligibility Criteria
You may qualify if:
- Patients older than 18 y/o
- Non-pedunculated rectal lesions (sessile 0-Is or flat 0-II) greater than 20 mm in diameter.
- The edges of the lesion should be more than 3 cm from the external anal margin and up to 14 cm from it.
- Circumferential involvement \<50%
You may not qualify if:
- Patients who refuse to participate.
- Diagnosis of inflammatory bowel disease with rectal involvement.
- Pregnant.
- Anorectal fibrosis due to previous anorectal surgery.
- Lateral Spreading Lesions (LST classification) Granular Homogeneous type
- Lesions greater than 50 mm when there is suspicion of advanced histology (Kudo Vi superficial pattern).
- Rectal lesions of any size with high suspicion of deep submucosal invasion or locoregional lymph node involvement, either in the diagnostic colonoscopy (Kudo Vn pit pattern, NICE 3 pattern, Sano IIIB pattern) or by complementary imaging tests (rectal EUS/Pelvic MRI)
- Existence of synchronous colorectal lesions that require other surgical treatment in any case.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hospital de Sant Joan Despí Moisès Broggi
Barcelona, Barcelona, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
Related Publications (1)
de Frutos Rosa D, Alonso Sebastian I, Barquero Declara D, Badia Closa J, Nogales O, Jimenez Gomez LM, Santiago Garcia J, Valentin Gomez F, Royuela Vicente A, Sanchez Movilla A, Albeniz E, Herreros de Tejada Echanojauregui A; Mucosal Resection; Third-Space Endoscopy Working Group from the Spanish Society of Gastrointestinal Endoscopy. A Randomized Trial of Endoscopic Submucosal Dissection vs Transanal Minimally Invasive Surgery in Early Rectal Neoplasms: DSETAMIS-2018 Study. Gastroenterology. 2026 Jan;170(1):161-173. doi: 10.1053/j.gastro.2025.07.029. Epub 2025 Jul 30.
PMID: 40749854DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Eduardo Albéniz, MD, PhD
Complejo Hospitalario de Navarra
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 16, 2019
First Posted
May 22, 2019
Study Start
April 1, 2019
Primary Completion
December 20, 2024
Study Completion
December 20, 2024
Last Updated
June 3, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share